申请人:Zhang Penglie
公开号:US20080269280A1
公开(公告)日:2008-10-30
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
提供了作为CCR1受体强效拮抗剂的化合物,并具有体内抗炎活性。这些化合物通常是单环和双环化合物,并且在制药组合物、用于治疗CCR1介导疾病的方法以及作为竞争性CCR1拮抗剂鉴定的控制物中很有用。